Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы

Neurological diseases and metabolism

Работ: 18

  1. Dracocephalum imberbe Bunge

    Shakhnoza S. Azimova, Anna I. Glushenkova

    ГлаваNeurological diseases and metabolism2012Цитирований: 0
    ABI

  2. Case study of sporadic multiple system atrophy at a young age

    Bakhrom Muinjonov, Elvina Giyazitdinova

    СтатьяNeurological diseases and metabolismParkinsonism & Related Disorders2015Цитирований: 0
    ABI

  3. Case study of sporadic multiple system atrophy at a young age

    Bakhrom Muinjonov, Elvina Giyazitdinova

    СтатьяNeurological diseases and metabolismParkinsonism & Related Disorders2015Цитирований: 0
    ABI

  4. Ефективність метилкобаламіну в метаболічній терапії діабетичної полінейропатії

    R. Azizova, D. Okhunova

    СтатьяNeurological Disorders and TreatmentsINTERNATIONAL NEUROLOGICAL JOURNAL2018Цитирований: 0
    ABI

  5. Angiogenesis in parkinson’s disease

    Y.N. Madjidova, Kh. A. Rasulova, S Fakhargalieva

    СтатьяParkinson's Disease Mechanisms and TreatmentsNATIONAL JOURNAL OF NEUROLOGY2018Цитирований: 0
    ABI

  6. Aspects of metabolic disorders in Parkinson's Disease, Vascular Parkinsonism and chronic cerebral ischemia

    Nigora Akramova, D. Akramova

    СтатьяParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences2021Цитирований: 0
    ABI

  7. Aspects of the vegetative disorders occurrence in the Parkinson's disease and Vascular Parkinsonism

    S.-J. Khamdamov, D. Akramova

    СтатьяParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences2021Цитирований: 0
    ABI

  8. Neutron Activation Analysis of Trace Elements in Parkinson’s Disease

    Е. А. Данилова, N. S. Osinskya, M. N. Khanova +1

    СтатьяNeurological diseases and metabolismMeditsinskaya Fizika2023Цитирований: 0
    ABI

  9. Significance of Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease

    Alexander V. Blagov, Anton Y. Postnov, Vasily N. Sukhorukov +3

    СтатьяParkinson's Disease Mechanisms and TreatmentsFrontiers in Bioscience-Landmark2024Цитирований: 0
    ABI

  10. CLINICAL CASE OF MULTISYSTEM ATROPHY WITH PARKINSONISM

    Naira F. Aripova, Umida T. Omonova

    СтатьяParkinson's Disease Mechanisms and TreatmentsThe American Journal of Medical Sciences and Pharmaceutical Research2024Цитирований: 0
    ABI

  11. Charcot Marie Tooth disease pathology is associated with mitochondrial dysfunction and lower glutathione production

    Nafisa R. Komilova, Plamena R. Angelova, Elisa Calì +5

    СтатьяHereditary Neurological DisordersCellular and Molecular Life Sciences2025Цитирований: 0
    ABI

  12. Serum ferritin levels in the exacerbation of motor symptoms in Parkinson's disease

    B. Muminov, Rustambek Matmurodov, O. Naimov +1

    СтатьяParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences2025Цитирований: 0
    ABI

  13. HEPATOLENTICULAR DEGENERATION: CLINICAL DIVERSITY ANDDIFFICULTIESOFEARLY DIAGNOSIS

    S.A. AVEZOV, A.В. JOBIRZODA, SH.G. GULOMOV +2

    СтатьяTrace Elements in HealthSCIENCE AND EDUCATION2026Цитирований: 0
    ABI

  14. Genetic Mechanisms and Early Diagnosis of Hereditary Polyneuropathy in Children

    Gaybiyev Akmaljon Ahmadjonovich, Mamurova Mavludakhon Mirhamzayevna

    СтатьяHereditary Neurological DisordersInternational Journal of Drug Delivery Technology2026Цитирований: 0
    ABI

  15. Familial Occurrence of Motor Neuron Disease: Genetic and Clinical Analysis

    Saida Akbarova

    СтатьяAmyotrophic Lateral Sclerosis ResearchZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  16. Familial Occurrence of Motor Neuron Disease: Genetic and Clinical Analysis

    Saida Akbarova

    СтатьяAmyotrophic Lateral Sclerosis ResearchZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  17. Serum ferritin, neutrophil-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio are associated with levodopa-induced dyskinesia severity in Parkinson’s disease

    F.S. Saidvaliyev, Dilyora Pulatova, I.A. Kilichev +8

    СтатьяParkinson's Disease Mechanisms and TreatmentsBMC Neurology2026Цитирований: 0
    ABI

  18. Peripheral Iron and Immune Markers Are Associated With Levodopa-Induced Dyskinesia Severity in Parkinson’s Disease

    F.S. Saidvaliyev, Dilyora Pulatova, I.A. Kilichev +8

    ПрепринтParkinson's Disease Mechanisms and TreatmentsResearch Square2026Цитирований: 0
    ABI